Pre-order Enquiry
Request Free Sample
Global Antiretroviral Therapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
SKU ID : QYR-21748256 | Publishing Date : 21-Sep-2022 | No. of pages : 104
Detailed TOC of Global Antiretroviral Therapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
1 Report Overview1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Antiretroviral Therapy Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 NNRTIs
1.2.3 NRTI
1.2.4 Multiclass Combination Products
1.2.5 Integrase Inhibitors
1.3 Market Segment by Application
1.3.1 Global Antiretroviral Therapy Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Antiretroviral Therapy Market Size (2017-2028)
2.1.1 Global Antiretroviral Therapy Revenue (2017-2028)
2.1.2 Global Antiretroviral Therapy Sales (2017-2028)
2.2 Global Antiretroviral Therapy Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Antiretroviral Therapy Sales by Regions (2017-2022)
2.2.2 Global Antiretroviral Therapy Revenue by Regions (2017-2022)
2.3 Global Antiretroviral Therapy Market Size Forecast by Region
2.3.1 Global Antiretroviral Therapy Sales Forecast by Region (2023-2028)
2.3.2 Global Antiretroviral Therapy Revenue Forecast by Region (2023-2028)
2.4 Global Top Antiretroviral Therapy Regions (Countries) Ranking by Market Size
2.5 Antiretroviral Therapy Market Dynamics
2.5.1 Antiretroviral Therapy Market Trends
2.5.2 Antiretroviral Therapy Market Drivers
2.5.3 Antiretroviral Therapy Market Challenges
2.5.4 Antiretroviral Therapy Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Antiretroviral Therapy Manufacturers by Sales (2017-2022)
3.1.1 Global Antiretroviral Therapy Sales by Manufacturers (2017-2022)
3.1.2 Global Antiretroviral Therapy Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Antiretroviral Therapy Sales in 2021
3.2 Global Top Manufacturers Antiretroviral Therapy by Revenue
3.2.1 Global Antiretroviral Therapy Revenue by Manufacturers (2017-2022)
3.2.2 Top Antiretroviral Therapy Manufacturers Covered: Ranking by Revenue
3.2.3 Global Antiretroviral Therapy Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Antiretroviral Therapy Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiretroviral Therapy as of 2021)
3.4 Global Antiretroviral Therapy Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Antiretroviral Therapy Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Antiretroviral Therapy Market
3.7 Key Manufacturers Antiretroviral Therapy Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Antiretroviral Therapy Market Size by Type
4.1 Global Antiretroviral Therapy Historic Market Review by Type (2017-2022)
4.1.1 Global Antiretroviral Therapy Sales Market Share by Type (2017-2022)
4.1.2 Global Antiretroviral Therapy Revenue Market Share by Type (2017-2022)
4.1.3 Antiretroviral Therapy Price by Type (2017-2022)
4.2 Global Antiretroviral Therapy Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Antiretroviral Therapy Sales Forecast by Type (2023-2028)
4.2.2 Global Antiretroviral Therapy Revenue Forecast by Type (2023-2028)
4.2.3 Antiretroviral Therapy Price Forecast by Type (2023-2028)
5 Global Antiretroviral Therapy Market Size by Application
5.1 Global Antiretroviral Therapy Historic Market Review by Application (2017-2022)
5.1.1 Global Antiretroviral Therapy Sales Market Share by Application (2017-2022)
5.1.2 Global Antiretroviral Therapy Revenue Market Share by Application (2017-2022)
5.1.3 Antiretroviral Therapy Price by Application (2017-2022)
5.2 Global Antiretroviral Therapy Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Antiretroviral Therapy Sales Forecast by Application (2023-2028)
5.2.2 Global Antiretroviral Therapy Revenue Forecast by Application (2023-2028)
5.2.3 Antiretroviral Therapy Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antiretroviral Therapy Sales Breakdown by Company
6.1.1 North America Antiretroviral Therapy Sales by Company (2017-2022)
6.1.2 North America Antiretroviral Therapy Revenue by Company (2017-2022)
6.2 North America Antiretroviral Therapy Market Size by Type
6.2.1 North America Antiretroviral Therapy Sales by Type (2017-2028)
6.2.2 North America Antiretroviral Therapy Revenue by Type (2017-2028)
6.3 North America Antiretroviral Therapy Market Size by Application
6.3.1 North America Antiretroviral Therapy Sales by Application (2017-2028)
6.3.2 North America Antiretroviral Therapy Revenue by Application (2017-2028)
6.4 North America Antiretroviral Therapy Market Size by Country
6.4.1 North America Antiretroviral Therapy Sales by Country (2017-2028)
6.4.2 North America Antiretroviral Therapy Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Antiretroviral Therapy Sales Breakdown by Company
7.1.1 Europe Antiretroviral Therapy Sales by Company (2017-2022)
7.1.2 Europe Antiretroviral Therapy Revenue by Company (2017-2022)
7.2 Europe Antiretroviral Therapy Market Size by Type
7.2.1 Europe Antiretroviral Therapy Sales by Type (2017-2028)
7.2.2 Europe Antiretroviral Therapy Revenue by Type (2017-2028)
7.3 Europe Antiretroviral Therapy Market Size by Application
7.3.1 Europe Antiretroviral Therapy Sales by Application (2017-2028)
7.3.2 Europe Antiretroviral Therapy Revenue by Application (2017-2028)
7.4 Europe Antiretroviral Therapy Market Size by Country
7.4.1 Europe Antiretroviral Therapy Sales by Country (2017-2028)
7.4.2 Europe Antiretroviral Therapy Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antiretroviral Therapy Sales Breakdown by Company
8.1.1 Asia Pacific Antiretroviral Therapy Sales by Company (2017-2022)
8.1.2 Asia Pacific Antiretroviral Therapy Revenue by Company (2017-2022)
8.2 Asia Pacific Antiretroviral Therapy Market Size by Type
8.2.1 Asia Pacific Antiretroviral Therapy Sales by Type (2017-2028)
8.2.2 Asia Pacific Antiretroviral Therapy Revenue by Type (2017-2028)
8.3 Asia Pacific Antiretroviral Therapy Market Size by Application
8.3.1 Asia Pacific Antiretroviral Therapy Sales by Application (2017-2028)
8.3.2 Asia Pacific Antiretroviral Therapy Revenue by Application (2017-2028)
8.4 Asia Pacific Antiretroviral Therapy Market Size by Region
8.4.1 Asia Pacific Antiretroviral Therapy Sales by Region
8.4.2 Asia Pacific Antiretroviral Therapy Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Antiretroviral Therapy Sales Breakdown by Company
9.1.1 Latin America Antiretroviral Therapy Sales by Company (2017-2022)
9.1.2 Latin America Antiretroviral Therapy Revenue by Company (2017-2022)
9.2 Latin America Antiretroviral Therapy Market Size by Type
9.2.1 Latin America Antiretroviral Therapy Sales by Type (2017-2028)
9.2.2 Latin America Antiretroviral Therapy Revenue by Type (2017-2028)
9.3 Latin America Antiretroviral Therapy Market Size by Application
9.3.1 Latin America Antiretroviral Therapy Sales by Application (2017-2028)
9.3.2 Latin America Antiretroviral Therapy Revenue by Application (2017-2028)
9.4 Latin America Antiretroviral Therapy Market Size by Country
9.4.1 Latin America Antiretroviral Therapy Sales by Country (2017-2028)
9.4.2 Latin America Antiretroviral Therapy Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antiretroviral Therapy Sales Breakdown by Company
10.1.1 Middle East and Africa Antiretroviral Therapy Sales by Company (2017-2022)
10.1.2 Middle East and Africa Antiretroviral Therapy Revenue by Company (2017-2022)
10.2 Middle East and Africa Antiretroviral Therapy Market Size by Type
10.2.1 Middle East and Africa Antiretroviral Therapy Sales by Type (2017-2028)
10.2.2 Middle East and Africa Antiretroviral Therapy Revenue by Type (2017-2028)
10.3 Middle East and Africa Antiretroviral Therapy Market Size by Application
10.3.1 Middle East and Africa Antiretroviral Therapy Sales by Application (2017-2028)
10.3.2 Middle East and Africa Antiretroviral Therapy Revenue by Application (2017-2028)
10.4 Middle East and Africa Antiretroviral Therapy Market Size by Country
10.4.1 Middle East and Africa Antiretroviral Therapy Sales by Country (2017-2028)
10.4.2 Middle East and Africa Antiretroviral Therapy Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Gilead
11.1.1 Gilead Corporation Information
11.1.2 Gilead Overview
11.1.3 Gilead Antiretroviral Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Gilead Antiretroviral Therapy Products and Services
11.1.5 Gilead Antiretroviral Therapy SWOT Analysis
11.1.6 Gilead Recent Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Corporation Information
11.2.2 F. Hoffmann-La Roche Overview
11.2.3 F. Hoffmann-La Roche Antiretroviral Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 F. Hoffmann-La Roche Antiretroviral Therapy Products and Services
11.2.5 F. Hoffmann-La Roche Antiretroviral Therapy SWOT Analysis
11.2.6 F. Hoffmann-La Roche Recent Developments
11.3 ViiV Healthcare
11.3.1 ViiV Healthcare Corporation Information
11.3.2 ViiV Healthcare Overview
11.3.3 ViiV Healthcare Antiretroviral Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 ViiV Healthcare Antiretroviral Therapy Products and Services
11.3.5 ViiV Healthcare Antiretroviral Therapy SWOT Analysis
11.3.6 ViiV Healthcare Recent Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Corporation Information
11.4.2 Boehringer Ingelheim Overview
11.4.3 Boehringer Ingelheim Antiretroviral Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Boehringer Ingelheim Antiretroviral Therapy Products and Services
11.4.5 Boehringer Ingelheim Antiretroviral Therapy SWOT Analysis
11.4.6 Boehringer Ingelheim Recent Developments
11.5 Janssen Pharmaceuticals
11.5.1 Janssen Pharmaceuticals Corporation Information
11.5.2 Janssen Pharmaceuticals Overview
11.5.3 Janssen Pharmaceuticals Antiretroviral Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Janssen Pharmaceuticals Antiretroviral Therapy Products and Services
11.5.5 Janssen Pharmaceuticals Antiretroviral Therapy SWOT Analysis
11.5.6 Janssen Pharmaceuticals Recent Developments
11.6 Mylan
11.6.1 Mylan Corporation Information
11.6.2 Mylan Overview
11.6.3 Mylan Antiretroviral Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Mylan Antiretroviral Therapy Products and Services
11.6.5 Mylan Antiretroviral Therapy SWOT Analysis
11.6.6 Mylan Recent Developments
11.7 Abbvie
11.7.1 Abbvie Corporation Information
11.7.2 Abbvie Overview
11.7.3 Abbvie Antiretroviral Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Abbvie Antiretroviral Therapy Products and Services
11.7.5 Abbvie Antiretroviral Therapy SWOT Analysis
11.7.6 Abbvie Recent Developments
11.8 Bionor Pharma
11.8.1 Bionor Pharma Corporation Information
11.8.2 Bionor Pharma Overview
11.8.3 Bionor Pharma Antiretroviral Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Bionor Pharma Antiretroviral Therapy Products and Services
11.8.5 Bionor Pharma Antiretroviral Therapy SWOT Analysis
11.8.6 Bionor Pharma Recent Developments
11.9 Vertex Pharmaceuticals
11.9.1 Vertex Pharmaceuticals Corporation Information
11.9.2 Vertex Pharmaceuticals Overview
11.9.3 Vertex Pharmaceuticals Antiretroviral Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Vertex Pharmaceuticals Antiretroviral Therapy Products and Services
11.9.5 Vertex Pharmaceuticals Antiretroviral Therapy SWOT Analysis
11.9.6 Vertex Pharmaceuticals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Antiretroviral Therapy Value Chain Analysis
12.2 Antiretroviral Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antiretroviral Therapy Production Mode & Process
12.4 Antiretroviral Therapy Sales and Marketing
12.4.1 Antiretroviral Therapy Sales Channels
12.4.2 Antiretroviral Therapy Distributors
12.5 Antiretroviral Therapy Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global Antiretroviral Therapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
List of TablesTable 1. Global Antiretroviral Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of NNRTIs
Table 3. Major Manufacturers of NRTI
Table 4. Major Manufacturers of Multiclass Combination Products
Table 5. Major Manufacturers of Integrase Inhibitors
Table 6. Global Antiretroviral Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Antiretroviral Therapy Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Antiretroviral Therapy Sales by Region (2017-2022) & (KG)
Table 9. Global Antiretroviral Therapy Sales Market Share by Region (2017-2022)
Table 10. Global Antiretroviral Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Antiretroviral Therapy Revenue Market Share by Region (2017-2022)
Table 12. Global Antiretroviral Therapy Sales Forecast by Region (2023-2028) & (KG)
Table 13. Global Antiretroviral Therapy Sales Market Share Forecast by Region (2023-2028)
Table 14. Global Antiretroviral Therapy Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 15. Global Antiretroviral Therapy Revenue Market Share Forecast by Region (2023-2028)
Table 16. Top Antiretroviral Therapy Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 17. Antiretroviral Therapy Market Trends
Table 18. Antiretroviral Therapy Market Drivers
Table 19. Antiretroviral Therapy Market Challenges
Table 20. Antiretroviral Therapy Market Restraints
Table 21. Global Antiretroviral Therapy Sales by Manufacturers (2017-2022) & (KG)
Table 22. Global Antiretroviral Therapy Sales Share by Manufacturers (2017-2022)
Table 23. Global Antiretroviral Therapy Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Ranking of Global Top Antiretroviral Therapy Manufacturers by Revenue (US$ Million) in 2021
Table 25. Antiretroviral Therapy Revenue Share by Manufacturers (2017-2022)
Table 26. Global Antiretroviral Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiretroviral Therapy as of 2021)
Table 28. Key Manufacturers Antiretroviral Therapy Average Selling Price (ASP) & (2017-2022) & (USD/KG)
Table 29. Key Manufacturers Antiretroviral Therapy Plants/Factories Distribution
Table 30. Key Manufacturers Antiretroviral Therapy Area Served
Table 31. Date of Key Manufacturers Enter into Antiretroviral Therapy Market
Table 32. Key Manufacturers Antiretroviral Therapy Product Type
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Antiretroviral Therapy Sales (KG) by Type (2017-2022)
Table 35. Global Antiretroviral Therapy Sales Share by Type (2017-2022)
Table 36. Global Antiretroviral Therapy Revenue (US$ Million) Market Share by Type (2017-2022)
Table 37. Global Antiretroviral Therapy Price (KG) by Type (2017-2022)
Table 38. Global Antiretroviral Therapy Sales (KG) by Type (2023-2028)
Table 39. Global Antiretroviral Therapy Sales Share by Type (2023-2028)
Table 40. Global Antiretroviral Therapy Revenue (US$ Million) Market Share by Type (2023-2028)
Table 41. Global Antiretroviral Therapy Revenue Share by Type (2023-2028)
Table 42. Global Antiretroviral Therapy Price (KG) by Type (2023-2028)
Table 43. Global Antiretroviral Therapy Sales (KG) by Application (2017-2022)
Table 44. Global Antiretroviral Therapy Sales Share by Application (2017-2022)
Table 45. Global Antiretroviral Therapy Revenue (US$ Million) Market Share by Application (2017-2022)
Table 46. Global Antiretroviral Therapy Price (KG) by Application (2017-2022)
Table 47. Global Antiretroviral Therapy Sales (KG) by Application (2023-2028)
Table 48. Global Antiretroviral Therapy Sales Share by Application (2023-2028)
Table 49. Global Antiretroviral Therapy Revenue (US$ Million) Market Share by Application (2023-2028)
Table 50. Global Antiretroviral Therapy Revenue Share by Application (2023-2028)
Table 51. Global Antiretroviral Therapy Price (KG) by Application (2023-2028)
Table 52. North America Antiretroviral Therapy Sales by Company (2017-2022) & (KG)
Table 53. North America Antiretroviral Therapy Sales Market Share by Company (2017-2022)
Table 54. North America Antiretroviral Therapy Revenue by Company (2017-2022) & (US$ Million)
Table 55. North America Antiretroviral Therapy Revenue Market Share by Company (2017-2022)
Table 56. North America Antiretroviral Therapy Sales by Type (2017-2022) & (KG)
Table 57. North America Antiretroviral Therapy Sales by Type (2023-2028) & (KG)
Table 58. North America Antiretroviral Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 59. North America Antiretroviral Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 60. North America Antiretroviral Therapy Sales by Application (2017-2022) & (KG)
Table 61. North America Antiretroviral Therapy Sales by Application (2023-2028) & (KG)
Table 62. North America Antiretroviral Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 63. North America Antiretroviral Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 64. North America Antiretroviral Therapy Sales by Country (2017-2022) & (KG)
Table 65. North America Antiretroviral Therapy Sales by Country (2023-2028) & (KG)
Table 66. North America Antiretroviral Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 67. North America Antiretroviral Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 68. Europe Antiretroviral Therapy Sales by Company (2017-2022) & (KG)
Table 69. Europe Antiretroviral Therapy Sales Market Share by Company (2017-2022)
Table 70. Europe Antiretroviral Therapy Revenue by Company (2017-2022) & (US$ Million)
Table 71. Europe Antiretroviral Therapy Revenue Market Share by Company (2017-2022)
Table 72. Europe Antiretroviral Therapy Sales by Type (2017-2022) & (KG)
Table 73. Europe Antiretroviral Therapy Sales by Type (2023-2028) & (KG)
Table 74. Europe Antiretroviral Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 75. Europe Antiretroviral Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 76. Europe Antiretroviral Therapy Sales by Application (2017-2022) & (KG)
Table 77. Europe Antiretroviral Therapy Sales by Application (2023-2028) & (KG)
Table 78. Europe Antiretroviral Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 79. Europe Antiretroviral Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 80. Europe Antiretroviral Therapy Sales by Country (2017-2022) & (KG)
Table 81. Europe Antiretroviral Therapy Sales by Country (2023-2028) & (KG)
Table 82. Europe Antiretroviral Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 83. Europe Antiretroviral Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 84. Asia Pacific Antiretroviral Therapy Sales by Company (2017-2022) & (KG)
Table 85. Asia Pacific Antiretroviral Therapy Sales Market Share by Company (2017-2022)
Table 86. Asia Pacific Antiretroviral Therapy Revenue by Company (2017-2022) & (US$ Million)
Table 87. Asia Pacific Antiretroviral Therapy Revenue Market Share by Company (2017-2022)
Table 88. Asia Pacific Antiretroviral Therapy Sales by Type (2017-2022) & (KG)
Table 89. Asia Pacific Antiretroviral Therapy Sales by Type (2023-2028) & (KG)
Table 90. Asia Pacific Antiretroviral Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 91. Asia Pacific Antiretroviral Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 92. Asia Pacific Antiretroviral Therapy Sales by Application (2017-2022) & (KG)
Table 93. Asia Pacific Antiretroviral Therapy Sales by Application (2023-2028) & (KG)
Table 94. Asia Pacific Antiretroviral Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 95. Asia Pacific Antiretroviral Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 96. Asia Pacific Antiretroviral Therapy Sales by Region (2017-2022) & (KG)
Table 97. Asia Pacific Antiretroviral Therapy Sales by Region (2023-2028) & (KG)
Table 98. Asia Pacific Antiretroviral Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 99. Asia Pacific Antiretroviral Therapy Revenue by Region (2023-2028) & (US$ Million)
Table 100. Latin America Antiretroviral Therapy Sales by Company (2017-2022) & (KG)
Table 101. Latin America Antiretroviral Therapy Sales Market Share by Company (2017-2022)
Table 102. Latin America Antiretroviral Therapy Revenue by Company (2017-2022) & (US$ Million)
Table 103. Latin America Antiretroviral Therapy Revenue Market Share by Company (2017-2022)
Table 104. Latin America Antiretroviral Therapy Sales by Type (2017-2022) & (KG)
Table 105. Latin America Antiretroviral Therapy Sales by Type (2023-2028) & (KG)
Table 106. Latin America Antiretroviral Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 107. Latin America Antiretroviral Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 108. Latin America Antiretroviral Therapy Sales by Application (2017-2022) & (KG)
Table 109. Latin America Antiretroviral Therapy Sales by Application (2023-2028) & (KG)
Table 110. Latin America Antiretroviral Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 111. Latin America Antiretroviral Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 112. Latin America Antiretroviral Therapy Sales by Country (2017-2022) & (KG)
Table 113. Latin America Antiretroviral Therapy Sales by Country (2023-2028) & (KG)
Table 114. Latin America Antiretroviral Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 115. Latin America Antiretroviral Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 116. Middle East and Africa Antiretroviral Therapy Sales by Company (2017-2022) & (KG)
Table 117. Middle East and Africa Antiretroviral Therapy Sales Market Share by Company (2017-2022)
Table 118. Middle East and Africa Antiretroviral Therapy Revenue by Company (2017-2022) & (US$ Million)
Table 119. Middle East and Africa Antiretroviral Therapy Revenue Market Share by Company (2017-2022)
Table 120. Middle East and Africa Antiretroviral Therapy Sales by Type (2017-2022) & (KG)
Table 121. Middle East and Africa Antiretroviral Therapy Sales by Type (2023-2028) & (KG)
Table 122. Middle East and Africa Antiretroviral Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 123. Middle East and Africa Antiretroviral Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 124. Middle East and Africa Antiretroviral Therapy Sales by Application (2017-2022) & (KG)
Table 125. Middle East and Africa Antiretroviral Therapy Sales by Application (2023-2028) & (KG)
Table 126. Middle East and Africa Antiretroviral Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 127. Middle East and Africa Antiretroviral Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 128. Middle East and Africa Antiretroviral Therapy Sales by Country (2017-2022) & (KG)
Table 129. Middle East and Africa Antiretroviral Therapy Sales by Country (2023-2028) & (KG)
Table 130. Middle East and Africa Antiretroviral Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 131. Middle East and Africa Antiretroviral Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 132. Gilead Corporation Information
Table 133. Gilead Description and Overview
Table 134. Gilead Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2017-2022)
Table 135. Gilead Antiretroviral Therapy Product and Services
Table 136. Gilead Antiretroviral Therapy SWOT Analysis
Table 137. Gilead Recent Developments
Table 138. F. Hoffmann-La Roche Corporation Information
Table 139. F. Hoffmann-La Roche Description and Overview
Table 140. F. Hoffmann-La Roche Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2017-2022)
Table 141. F. Hoffmann-La Roche Antiretroviral Therapy Product and Services
Table 142. F. Hoffmann-La Roche Antiretroviral Therapy SWOT Analysis
Table 143. F. Hoffmann-La Roche Recent Developments
Table 144. ViiV Healthcare Corporation Information
Table 145. ViiV Healthcare Description and Overview
Table 146. ViiV Healthcare Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2017-2022)
Table 147. ViiV Healthcare Antiretroviral Therapy Product and Services
Table 148. ViiV Healthcare Antiretroviral Therapy SWOT Analysis
Table 149. ViiV Healthcare Recent Developments
Table 150. Boehringer Ingelheim Corporation Information
Table 151. Boehringer Ingelheim Description and Overview
Table 152. Boehringer Ingelheim Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2017-2022)
Table 153. Boehringer Ingelheim Antiretroviral Therapy Product and Services
Table 154. Boehringer Ingelheim Antiretroviral Therapy SWOT Analysis
Table 155. Boehringer Ingelheim Recent Developments
Table 156. Janssen Pharmaceuticals Corporation Information
Table 157. Janssen Pharmaceuticals Description and Overview
Table 158. Janssen Pharmaceuticals Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2017-2022)
Table 159. Janssen Pharmaceuticals Antiretroviral Therapy Product and Services
Table 160. Janssen Pharmaceuticals Antiretroviral Therapy SWOT Analysis
Table 161. Janssen Pharmaceuticals Recent Developments
Table 162. Mylan Corporation Information
Table 163. Mylan Description and Overview
Table 164. Mylan Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2017-2022)
Table 165. Mylan Antiretroviral Therapy Product and Services
Table 166. Mylan Antiretroviral Therapy SWOT Analysis
Table 167. Mylan Recent Developments
Table 168. Abbvie Corporation Information
Table 169. Abbvie Description and Overview
Table 170. Abbvie Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2017-2022)
Table 171. Abbvie Antiretroviral Therapy Product and Services
Table 172. Abbvie Antiretroviral Therapy SWOT Analysis
Table 173. Abbvie Recent Developments
Table 174. Bionor Pharma Corporation Information
Table 175. Bionor Pharma Description and Overview
Table 176. Bionor Pharma Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2017-2022)
Table 177. Bionor Pharma Antiretroviral Therapy Product and Services
Table 178. Bionor Pharma Antiretroviral Therapy SWOT Analysis
Table 179. Bionor Pharma Recent Developments
Table 180. Vertex Pharmaceuticals Corporation Information
Table 181. Vertex Pharmaceuticals Description and Overview
Table 182. Vertex Pharmaceuticals Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2017-2022)
Table 183. Vertex Pharmaceuticals Antiretroviral Therapy Product and Services
Table 184. Vertex Pharmaceuticals Antiretroviral Therapy SWOT Analysis
Table 185. Vertex Pharmaceuticals Recent Developments
Table 186. Key Raw Materials Lists
Table 187. Raw Materials Key Suppliers Lists
Table 188. Antiretroviral Therapy Distributors List
Table 189. Antiretroviral Therapy Customers List
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiretroviral Therapy Product Picture
Figure 2. Global Antiretroviral Therapy Sales Market Share by Type in 2021 & 2028
Figure 3. NNRTIs Product Picture
Figure 4. NRTI Product Picture
Figure 5. Multiclass Combination Products Product Picture
Figure 6. Integrase Inhibitors Product Picture
Figure 7. Global Antiretroviral Therapy Sales Market Share by Application in 2021 & 2028
Figure 8. Hospital Use Case
Figure 9. Clinic Use Case
Figure 10. Other Use Case
Figure 11. Antiretroviral Therapy Report Years Considered
Figure 12. Global Antiretroviral Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Antiretroviral Therapy Market Size 2017-2028 (US$ Million)
Figure 14. Global Antiretroviral Therapy Sales (2017-2022) & (KG)
Figure 15. Global Antiretroviral Therapy Market Size Market Share by Region: 2021 VS 2028
Figure 16. Global Antiretroviral Therapy Sales Market Share by Region (2017-2022)
Figure 17. Global Antiretroviral Therapy Sales Market Share by Region in 2021
Figure 18. Global Antiretroviral Therapy Revenue Market Share by Region in 2017 VS 2021
Figure 19. Global Antiretroviral Therapy Sales Share by Manufacturers in 2021
Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by Antiretroviral Therapy Sales in 2021
Figure 21. Antiretroviral Therapy Revenue Share by Manufacturers in 2021
Figure 22. Antiretroviral Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 23. Global Antiretroviral Therapy Revenue Share by Type (2017-2022)
Figure 24. Global Antiretroviral Therapy Revenue Growth Rate by Type in 2017 & 2021
Figure 25. Global Antiretroviral Therapy Revenue Share by Application (2017-2022)
Figure 26. Global Antiretroviral Therapy Revenue Growth Rate by Application in 2017 & 2021
Figure 27. North America Antiretroviral Therapy Sales Market Share by Type (2017-2028)
Figure 28. North America Antiretroviral Therapy Revenue Market Share by Type (2017-2028)
Figure 29. North America Antiretroviral Therapy Sales Market Share by Application (2017-2028)
Figure 30. North America Antiretroviral Therapy Revenue Market Share by Application (2017-2028)
Figure 31. North America Antiretroviral Therapy Sales Share by Country (2017-2028)
Figure 32. North America Antiretroviral Therapy Revenue Share by Country (2017-2028)
Figure 33. U.S. Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 34. Canada Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 35. Europe Antiretroviral Therapy Sales Market Share by Type (2017-2028)
Figure 36. Europe Antiretroviral Therapy Revenue Market Share by Type (2017-2028)
Figure 37. Europe Antiretroviral Therapy Sales Market Share by Application (2017-2028)
Figure 38. Europe Antiretroviral Therapy Revenue Market Share by Application (2017-2028)
Figure 39. Europe Antiretroviral Therapy Sales Share by Country (2017-2028)
Figure 40. Europe Antiretroviral Therapy Revenue Share by Country (2017-2028)
Figure 41. Germany Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 42. France Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 43. U.K. Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 44. Italy Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 45. Russia Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 46. Asia Pacific Antiretroviral Therapy Sales Market Share by Type (2017-2028)
Figure 47. Asia Pacific Antiretroviral Therapy Revenue Market Share by Type (2017-2028)
Figure 48. Asia Pacific Antiretroviral Therapy Sales Market Share by Application (2017-2028)
Figure 49. Asia Pacific Antiretroviral Therapy Revenue Market Share by Application (2017-2028)
Figure 50. Asia Pacific Antiretroviral Therapy Sales Share by Region (2017-2028)
Figure 51. Asia Pacific Antiretroviral Therapy Revenue Share by Region (2017-2028)
Figure 52. China Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 53. Japan Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 54. South Korea Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 55. India Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 56. Australia Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 57. China Taiwan Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 58. Indonesia Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 59. Thailand Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 60. Malaysia Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 61. Latin America Antiretroviral Therapy Sales Market Share by Type (2017-2028)
Figure 62. Latin America Antiretroviral Therapy Revenue Market Share by Type (2017-2028)
Figure 63. Latin America Antiretroviral Therapy Sales Market Share by Application (2017-2028)
Figure 64. Latin America Antiretroviral Therapy Revenue Market Share by Application (2017-2028)
Figure 65. Latin America Antiretroviral Therapy Sales Share by Country (2017-2028)
Figure 66. Latin America Antiretroviral Therapy Revenue Share by Country (2017-2028)
Figure 67. Mexico Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 68. Brazil Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 69. Argentina Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 70. Middle East and Africa Antiretroviral Therapy Sales Market Share by Type (2017-2028)
Figure 71. Middle East and Africa Antiretroviral Therapy Revenue Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Antiretroviral Therapy Sales Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Antiretroviral Therapy Revenue Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Antiretroviral Therapy Sales Share by Country (2017-2028)
Figure 75. Middle East and Africa Antiretroviral Therapy Revenue Share by Country (2017-2028)
Figure 76. Turkey Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 77. Saudi Arabia Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 78. UAE Antiretroviral Therapy Revenue (2017-2028) & (US$ Million)
Figure 79. Antiretroviral Therapy Value Chain
Figure 80. Antiretroviral Therapy Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
Keyplayers in Global Antiretroviral Therapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
GileadF. Hoffmann-La Roche
ViiV Healthcare
Boehringer Ingelheim
Janssen Pharmaceuticals
Mylan
Abbvie
Bionor Pharma
Vertex Pharmaceuticals
Request Sample
Request Discount
